【摘要】 目的观察盐酸氨溴索联合盐酸丙卡特罗治疗小儿肺炎的临床疗效。方法选取2015年1月至2020年1月我院收治的200例肺炎患儿,随机分为对照组和研究组各100例。对照组采用常规治疗,研究组在对照组基础上采用盐酸氨溴索联合盐酸丙卡特罗治疗。治疗10 d后,比较两组患儿的临床症状消失时间、临床疗效及不良反应发生情况。结果研究组的退热时间、止咳时间、肺部啰音消失时间均明显短于对照组(P <0.05)。研究组治疗总有效率为95.00%,明显高于对照组的85.00%(P <0.05)。治疗期间,两组患儿的不良反应发生率(3.00%vs. 1.00%)比较差异无统计学意义(P>0.05)。结论盐酸氨溴索联合盐酸丙卡特罗治疗小儿肺炎安全有效,并可有效缓解患儿相关症状,值得临床推广应用。更多还原

【Abstract】 Objective To observe the clinical efficacy of ambroxol hydrochloride combined with procaterol hydrochloride in the treatment of children with pneumonia. Methods 200 children with pneumonia admitted to our hospital from January 2015 to January 2020 were selected and randomly divided into control group and study group, with 100 cases in each group. The control group was given routine treatment, and the study group was treated with ambroxol hydrochloride combined with procaterol hydrochloride on the basis of the control group. After 10 days of treatment, the disappearance time of clinical symptoms, clinical efficacy and adverse reactions were compared between the two groups. Results The antipyretic time, cough relief time and disappearance time of lung rale in the study group were significantly shorter than those in the control group(P <0.05). The total effective rate of treatment in the study group was 95.00%,significantly higher than 85.00% in the control group(P <0.05). During the treatment, no statistical difference was found in the incidence of adverse reactions(3.00% vs. 1.00%) between the two groups(P >0.05). Conclusions Ambroxol hydrochloride combined with procaterol hydrochloride is safe and effective in the treatment of children with pneumonia, and can effectively alleviate the related symptoms in children, which is worthy of clinical promition and application.更多还原